Status:
TERMINATED
Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients
Lead Sponsor:
Sanofi
Conditions:
Pharyngotonsillitis
Eligibility:
All Genders
4-11 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the inflammatory symptoms and signs (hyperemia, edema and pain) reduction after 24 hours of treatment with ketoprofen drops when associated to amoxicillin.
Detailed Description
The total duration of the study period per patient is 10 ± 1 day
Eligibility Criteria
Inclusion
- Quick-test positive for Streptococcus pyogenes;
- Indication for treatment with amoxicillin according to labeling and physician's clinical evaluation;
- Pain (for swallowing) evaluated by Wong Baker Faces Pain scale with at least grade 3;
- Presence of at least two of the follow symptoms:
- Hyperemia and edema evaluated with at least 2 out of 4 crosses
- Fever in the previous 48 hours
- Cervical adenomegaly
- Tonsilla with erythema or erythema and white exsudate.
Exclusion
- History of cardiovascular, gastrointestinal, metabolic or psychiatric conditions;
- History and laboratorial confirmation of hematologic, hepatic or renal disorders;
- Use of nonsteroidal antiinflammatory drugs (NSAID) during the last 3 weeks and gastroesophageal reflux during the last 6 months;
- Use of analgesic or anti inflammatory medication (except Paracetamol) in the previous 12 hours;
- History of allergy or hypersensitivity to amoxicillin and/ or ketoprofen.
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00799838
Start Date
November 1 2008
End Date
June 1 2013
Last Update
October 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis Administrative Office
São Paulo, Brazil